Copyright
©The Author(s) 2024.
World J Gastroenterol. Feb 14, 2024; 30(6): 527-541
Published online Feb 14, 2024. doi: 10.3748/wjg.v30.i6.527
Published online Feb 14, 2024. doi: 10.3748/wjg.v30.i6.527
Figure 1 Canonical, non-canonical, and alternative modes of NOD-like receptor family pyrin domain containing 3 activation.
NLRP3: NOD-like receptor family pyrin domain containing 3; PAMPs: Pathogen-associated molecular patterns; TNF-α: Tumor necrosis factor-alpha; IL-1β: Interleukin-1β; ROS: Reactive oxygen species; GSDMD: Gasdermin D; LPS: Lipopolysaccharide; ASC: Apoptosis-associated speck-like protein; IL-18: Interleukin-18.
Figure 2 The processes of exosome biogenesis and release.
MVB: Multivesicular bodies.
Figure 3 Inhibition of NOD-like receptor family pyrin domain containing 3 inflammasome activation by stem cell-derived exosomes in ulcerative colitis.
NLRP3: NOD-like receptor family pyrin domain containing 3; MVB: Multivesicular bodies; GSDMD: Gasdermin D.
- Citation: Li X, Ji LJ, Feng KD, Huang H, Liang MR, Cheng SJ, Meng XD. Emerging role of exosomes in ulcerative colitis: Targeting NOD-like receptor family pyrin domain containing 3 inflammasome. World J Gastroenterol 2024; 30(6): 527-541
- URL: https://www.wjgnet.com/1007-9327/full/v30/i6/527.htm
- DOI: https://dx.doi.org/10.3748/wjg.v30.i6.527